JP2024521638A5 - - Google Patents
Info
- Publication number
- JP2024521638A5 JP2024521638A5 JP2023568153A JP2023568153A JP2024521638A5 JP 2024521638 A5 JP2024521638 A5 JP 2024521638A5 JP 2023568153 A JP2023568153 A JP 2023568153A JP 2023568153 A JP2023568153 A JP 2023568153A JP 2024521638 A5 JP2024521638 A5 JP 2024521638A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- fragment
- eosinophilic
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21172160.0A EP4085973A1 (en) | 2021-05-04 | 2021-05-04 | Inhibition of eosinophil extracellular traps |
| EP21172160.0 | 2021-05-04 | ||
| GB2111541.5 | 2021-08-11 | ||
| GB202111541 | 2021-08-11 | ||
| PCT/EP2022/061970 WO2022233931A1 (en) | 2021-05-04 | 2022-05-04 | Inhibition of eosinophilic traps |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521638A JP2024521638A (ja) | 2024-06-04 |
| JP2024521638A5 true JP2024521638A5 (https=) | 2025-05-15 |
Family
ID=81392799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568153A Pending JP2024521638A (ja) | 2021-05-04 | 2022-05-04 | 好酸球トラップの阻害 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250084154A1 (https=) |
| EP (1) | EP4333981A1 (https=) |
| JP (1) | JP2024521638A (https=) |
| KR (1) | KR20240005856A (https=) |
| AU (1) | AU2022270356A1 (https=) |
| CA (1) | CA3215452A1 (https=) |
| IL (1) | IL308223A (https=) |
| MX (1) | MX2023013021A (https=) |
| WO (1) | WO2022233931A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3841120B1 (en) | 2018-08-21 | 2025-09-24 | Citryll B.V. | Antibodies binding to citrullinated histone 2a and/or 4 |
| EP4442705A1 (en) | 2023-04-03 | 2024-10-09 | Citryll B.V. | Dosage |
| GB202318703D0 (en) | 2023-12-07 | 2024-01-24 | Citryll B V | Diagnostic agent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ612578A (en) | 2005-08-19 | 2014-11-28 | Abbvie Inc | Dual variable domain immunoglobin and uses thereof |
| EP2535349A1 (en) | 2007-09-26 | 2012-12-19 | UCB Pharma S.A. | Dual specificity antibody fusions |
| NO2294086T3 (https=) | 2008-06-04 | 2018-02-10 | ||
| CA2737241C (en) | 2008-09-26 | 2017-08-29 | Ucb Pharma S.A. | Multivalent antibody fusion proteins |
| WO2011030107A1 (en) | 2009-09-10 | 2011-03-17 | Ucb Pharma S.A. | Multivalent antibodies |
| EP2332987A1 (en) | 2009-12-10 | 2011-06-15 | ModiQuest B.V. | Anti-inflammatory agents directed against citrullinated epitopes |
| JP7037940B2 (ja) | 2014-12-11 | 2022-03-17 | シトリル べー．フェー． | 特発性肺線維症の治療方法 |
| EP3841120B1 (en) | 2018-08-21 | 2025-09-24 | Citryll B.V. | Antibodies binding to citrullinated histone 2a and/or 4 |
-
2022
- 2022-05-04 KR KR1020237041716A patent/KR20240005856A/ko active Pending
- 2022-05-04 JP JP2023568153A patent/JP2024521638A/ja active Pending
- 2022-05-04 MX MX2023013021A patent/MX2023013021A/es unknown
- 2022-05-04 US US18/289,559 patent/US20250084154A1/en active Pending
- 2022-05-04 IL IL308223A patent/IL308223A/en unknown
- 2022-05-04 WO PCT/EP2022/061970 patent/WO2022233931A1/en not_active Ceased
- 2022-05-04 EP EP22719601.1A patent/EP4333981A1/en active Pending
- 2022-05-04 AU AU2022270356A patent/AU2022270356A1/en active Pending
- 2022-05-04 CA CA3215452A patent/CA3215452A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521638A5 (https=) | ||
| EP1545611B1 (en) | Method of treatment of asthma using antibodies to complement component c5 | |
| JP6278536B2 (ja) | 関節炎治療 | |
| JP2022023049A (ja) | バイオ医薬組成物 | |
| JP2006500392A5 (https=) | ||
| KR20200128415A (ko) | 중증 천식 치료를 위한 항 cd6 항체 | |
| JP2024521638A (ja) | 好酸球トラップの阻害 | |
| JP2002538170A (ja) | 喘息の治療における抗−ＴＮＦα抗体 | |
| JP2025164767A (ja) | Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法 | |
| WO2020097566A1 (en) | Use of clazakizumab to desensitize and improve renal transplantation in hla-sensitized patients | |
| JP2021501213A5 (https=) | ||
| US20260008865A1 (en) | Antibodies, compositions, and methods of treatment | |
| WO2018226339A1 (en) | Biopharmaceutical compositions and methods for pediatric patients | |
| TW202417478A (zh) | 用於治療支氣管擴張的抗PcrV和Psl雙特異性藥物 | |
| JP2024511160A5 (https=) | ||
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 | |
| WO2020023619A2 (en) | Blood brain barrier selective antibodies and methods of use | |
| WO2024248127A1 (ja) | アレルギー疾患予防・治療薬 | |
| WO2025238121A1 (en) | Anti-il-5 antibody in the treatment of asthma | |
| JP2024529809A (ja) | アレルギー体質の個体群における抗ＩＬ－１３Ｒα１抗体またはその結合フラグメントを使用するアトピー性皮膚炎の処置 | |
| JP2023520216A5 (https=) | ||
| CN121219312A (zh) | 剂量方案 | |
| JP2026503045A (ja) | Ｔｓｌｐ抗体を使用して喘息を治療するための方法 | |
| AU2024344855A1 (en) | Il-5r-alpha antibodies for treating eosinophilic granulomatosis with polyangiitis | |
| EA052640B1 (ru) | Ингибирование внеклеточных ловушек |